Elicio Therapeutics, Inc.
ELTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001601485
No open-market purchases or sales by Elicio Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $15.3M in total; no superinvestor holds it.
Holders of 5% or more of ELTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Elicio Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Chudnovsky Yekaterina | 13D/A | 48.10%9.66M shares | – | Mar 7, 20251 filing | Mar 7, 2025 | SEC |
| GKCC, LLC | 13D/A | 48.00%9.76M shares | – | Jun 4, 20251 filing | Jun 4, 2025 | SEC |
| Knoll Capital Management, LLC | 13G | 5.20%630.9K shares | New | Feb 5, 20251 filing | Feb 5, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Elicio Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Oct 7, 202511:58 AM ET | Actyus Private Equity SGIIC, S.A. | 13G/A | 1.60%268.6K shares | −3.80 ppfrom 5.40%Below 5% | Sep 30, 2025 | SEC |
| Jun 4, 20255:06 PM ET | GKCC, LLCand 1 other | 13D/A | 48.00%9.76M shares | – | Jun 3, 2025 | SEC |
| May 14, 20259:26 AM ET | Actyus Private Equity SGIIC, S.A. | 13G/A | 5.40%856.4K shares | −0.05 ppfrom 5.45% | Mar 31, 2025 | SEC |
| Mar 7, 20254:07 PM ET | Chudnovsky Yekaterinaand 1 other | 13D/A | 48.10%9.66M shares | – | Mar 5, 2025 | SEC |
| Feb 5, 202511:10 AM ET | Knoll Capital Management, LLCand 2 others | 13G | 5.20%630.9K shares | New | Jan 30, 2025 | SEC |
| Jan 7, 20254:30 PM ET | Actyus Private Equity SGIIC, S.A. | 13G | 5.45%587.8K shares | New | Dec 8, 2023 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Elicio Therapeutics, Inc. shares.
No Form 144 notices for Elicio Therapeutics, Inc. are on file.